Stock 1099 SINOPHARM GROUP CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Sinopharm Group Co. Ltd.

Equities

1099

CNE100000FN7

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:06 2024-04-30 am EDT 		5-day change 1st Jan Change
19.84 HKD -1.78% Intraday chart for Sinopharm Group Co. Ltd. -5.52% -2.98%
Apr. 29 Wall Street Cues, Property Outlooks Lift Asian Stock Markets MT
Apr. 29 China, Hong Kong stocks rise, led by property shares RE

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wall Street Cues, Property Outlooks Lift Asian Stock Markets
MT
China, Hong Kong stocks rise, led by property shares
RE
Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sinopharm Group Shares Fall as Higher Costs Cut Into Quarterly Profit
DJ
Sinopharm Group's Q1 Profit Falls as Operating Costs Rise
MT
Central Bank, Tech Outlooks Lift Major Asian Stock Markets
MT
Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets
MT
China Production Bases of Shyndec Pharmaceutical's Unit Gets Compliance Certification from Australian Regulator
MT
Sinopharm's Attributable Profit Jumps in 2023 on Higher Revenue
MT
Sinopharm Group Co. Ltd. Proposes Final Dividend of for the Financial Year Ended 31 December 2023, Payable on 13 August 2024
CI
Sinopharm Group Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings
MT
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%
MT
China Traditional Chinese Medicine's Stock Bolts on Privatization Offer
MT
Sinopharm offers to take China-TCM private in nearly $3 bln deal
RE
Shyndec Pharma Unit's Cefotaxime Sodium for Injection Passes Drug Regulator's Consistency Evaluation
MT
Cancer Drug of Shyndec Pharma's Unit Passes Drug Regulator's Evaluation
MT
Sinopharm to Renew Financial Services Deal with Affiliate
MT
Hutchmed China renews deals with "substantial" shareholders
AN
Linklogis to Offload Entire 19.6% Stake in Pharma Supply Chain Financing Associate
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1099 Stock
  4. News Sinopharm Group Co. Ltd.
  5. Highlights